Tenovin-3

Tenovin-3

Catalog Number:
FC01365188APE
Mfr. No.:
APE-A8567
Price:
$452
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Tenovin SAR Studies Aimed at Increasing Water Solubility



          ID



          p53 Increasea
          K40Ac Tubulin Increaseb
          SirT2 Inhibitionc





          R1
          R2





          Tenovin-1
          tBu
          NHCOCH3
          +
          +
          +


          Tenovin-2
          tBu
          NHCOCH(CH3)2
          +
          +
          +


          Tenovin-3
          tBu
          NH2
          +
          +
          +


          Tenovin-4
          N3
          NHCOCH3





          Tenovin-5
          tBu
          NHCOPh
          +
          +
          +


          Tenovin-6
          tBu
          NHCO(CH2)4NMe2.HCl
          +
          +
          +



          a Ability to increase p53 levels was determined in MCF-7 cells treated for 6 hr at 10 μM.
          b Ability to increase K40 Ac-tubulin levels was determined in H1299 cells treated
          c SirT2 inhibition assessed using a compound concentration of 10 or 30 μM depending on the compound's solubility in the assay buffer.

      • Properties
        • Categories
          p53 activator
          Alternative Name
          Tenovin 3;Tenovin3; N-[(4-aminophenyl)carbamothioyl]-4-tert-butylbenzamide
          CAS Number
          1011301-27-1
          Molecular Formula
          C18H21N3OS
          Molecular Weight
          327.44
          Appearance
          A solid
          Purity
          99.85%
          Solubility
          insoluble in H2O; ≥14.45 mg/mL in DMSO; ≥2.88 mg/mL in EtOH with gentle warming
          Storage
          Store at -20°C
          SMILES
          CC(C)(C)C1=CC=C(C=C1)C(=O)NC(=S)NC2=CC=C(C=C2)N

          * For Research Use Only

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.